RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PERBELLINI R
Collezione AOU Novara

Items : 4

Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV. in JHEP reports : innovation in hepatology / JHEP Rep. 2024 Dec 11;7(3):101299. doi: 10.1016/j.jhepr.2024.101299. eCollection 2025 Mar.

2025
AOU Novara

Anolli MP; Uceda Renteria S; Degasperi E; Facchetti F; Sambarino D; Borghi M; Perbellini R; Soffredini R; Monico S; Callegaro A; Lampertico P;

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta. in Journal of hepatology / J Hepatol. 2025 Jun;82(6):1004-1011. doi: 10.1016/j.jhep.2024.11.051. Epub 2024 Dec 9.

2025
AOU Novara

Degasperi E; Scholtes C; Testoni B; Renteria SU; Anolli MP; Charre C; Facchetti F; Plissonnier ML; Sambarino D; Perbellini R; Monico S; Callegaro A; García-Pras E; Lens S; Cortese MF; Forns X; Pérez-Del-Pulgar S; Heil M; Levrero M; Zoulim F; Lampertico P;

Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide. in Journal of hepatology / J Hepatol. 2024 Nov;81(5):819-826. doi: 10.1016/j.jhep.2024.06.013. Epub 2024 Jun 18.

2024
AOU Novara

Toniutto P; Falleti E; Cmet S; Cussigh A; Degasperi E; Anolli MP; Sambarino D; Facchetti F; Borghi M; Perbellini R; Monico S; Lampertico P;

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. in The Lancet. Oncology / Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8.

2023
AOU Novara

Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; et alii...